Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2007
05/18/2007WO2007008937A3 Adiponectin variants
05/18/2007WO2007008069A3 A method for detecting peptides comprising a cross-b structure
05/18/2007WO2006134342A3 Mutants of human app and their use for the production of transgenic animals
05/18/2007WO2006131749A3 Scaffold
05/18/2007WO2006130328A3 Serum resistance factors of gram positive bacteria
05/18/2007WO2006114308A3 Carrier for targeting nerve cells
05/18/2007WO2006096757A3 Inhibitors of reca activities for control of antibiotic-resistant bacterial pathogens
05/18/2007WO2006081323A3 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin
05/18/2007WO2006074144A3 Cell free assay for determining a substance of interest and molecular complexes used therefore
05/18/2007WO2006055631A3 Casein kinase stress-related polypeptides and methods of use in plants
05/18/2007WO2006042848A9 Growth hormone conjugates
05/18/2007WO2006032216A3 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions
05/18/2007WO2006029487A8 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis
05/18/2007WO2006020868A3 Intracellular production of a nuclease
05/18/2007WO2005120565A3 Sars vaccines and methods to produce highly potent antibodies
05/18/2007WO2005111066A8 Polypeptides from non-typeable haemophilus influenzae
05/18/2007WO2005016241A3 Synthetic chemokine receptor ligands and methods of use thereof
05/18/2007WO2004103275A3 Compositions and methods for the preparation of human growth hormone glycosylation mutants
05/18/2007WO2004022593A8 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
05/18/2007WO2003077872A3 Cell surface tropomyosin as a target of angiogenesis inhibition
05/18/2007WO2002050249A3 Protein-protein interactions
05/18/2007CA2629522A1 Gene therapy for renal failure
05/18/2007CA2629376A1 Inhibitors of parp activity and uses thereof
05/18/2007CA2628860A1 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant
05/18/2007CA2628689A1 Productivity augmenting protein factor, novel cell lines and uses thereof
05/18/2007CA2628635A1 Mu-conotoxin peptides and use thereof as a local anesthetic
05/18/2007CA2628552A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies
05/18/2007CA2628546A1 Therapeutic vaccines targeting hmgb1
05/18/2007CA2628472A1 Surfactant protein-d for prevention and treatment of lung infections and sepsis
05/18/2007CA2626859A1 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
05/18/2007CA2626831A1 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance
05/18/2007CA2620726A1 Pyroglue
05/17/2007US20070113304 Antifreeze proteins isolated from forage grasses and methods for their use
05/17/2007US20070113303 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds
05/17/2007US20070113300 Clp-protease as target for herbicides
05/17/2007US20070113299 Transforming oviduct tissue of birds with nucleotide sequences coding mammalian polypeptides; bioreactors and heterologous gene expression; tissue engineering
05/17/2007US20070112179 Novel compounds
05/17/2007US20070112177 Adenosine receptor
05/17/2007US20070112176 Lipid membrane structure containing anti-mt-mmp monoclonal antibody
05/17/2007US20070112175 Determining drug resistance
05/17/2007US20070111957 Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
05/17/2007US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
05/17/2007US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action
05/17/2007US20070111944 Purification of vascular endothelial growth factor-B
05/17/2007US20070111943 Tetrodotoxin-resistant sodium channel alpha subunit
05/17/2007US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells
05/17/2007US20070111941 Cytokine receptor zalpha11
05/17/2007US20070111940 Peptide agonists of GLP-1 activity
05/17/2007US20070111939 Human interleukin-11 receptor
05/17/2007US20070111934 Procaspase 1 activation inhibitor
05/17/2007US20070111926 Conjugation of peptides
05/17/2007US20070111293 Genes from a gene cluster
05/17/2007US20070111288 Biosynthesis of botulinium toxins by anaerobic fermentation of Clostridium botulin toxins
05/17/2007US20070111287 Design of beta-sheet proteins with specific binding properties
05/17/2007US20070111286 Express the novel calcium channel subunits; cells may be used for identifying compounds capable of stimulating or inhibiting the activation of the calcium channels
05/17/2007US20070111285 Human skeletal muscle-specific ubiquitin-conjugating emzyme
05/17/2007US20070111284 Galactosylation of Recombinant Glycoproteins
05/17/2007US20070111282 Immunoglobulins; antibodies; complementary determining regions; immunoassay
05/17/2007US20070111280 Compositions and methods for non-targeted activation of endogenous genes
05/17/2007US20070111266 Antibodies to murine zcytor17 ligand
05/17/2007US20070111261 Antigens
05/17/2007US20070111253 Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
05/17/2007US20070111252 Alcadeins and amyloid precursor protein co-localization for use as evaluative and prognostic tools in monitoring dementia and nervous system degeneration
05/17/2007US20070111236 Streptococcus suis vaccines and diagnostic tests
05/17/2007US20070111232 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
05/17/2007US20070111230 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
05/17/2007US20070111214 20685, 579,17114, 23821, 33894 and 32613, novel human transporters
05/17/2007US20070111203 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
05/17/2007US20070111193 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
05/17/2007US20070110820 Bone Matrix Compositions and Methods
05/17/2007US20070110814 Bioactive polypeptide conjugated to the sulfate group; sustained release; alginate sulfate or sulfated hyaluronan conjugated to e.g. insulin, glatiramer acetate, antithrombin III, interferon gamma , IGF, somatostatin, luteinizing hormone-releasing hormone, erythropoietin, interleukins
05/17/2007US20070110809 Stabilised compositions
05/17/2007US20070110769 Clostridial toxin derivatives and methods for treating pain
05/17/2007US20070110767 An immunogenic mixture of a vector that contains and expresses in vivo in a porcine host cell and a nucleic acid molecule or fragment thereof encoding a porcine circovirus type B antigen
05/17/2007US20070110766 Proteinase K resistant surface protein of neisseria meningitidis
05/17/2007US20070110765 Helicobacter pylori bacterioferritin
05/17/2007US20070110764 Purified polypeptide having the amino acid sequence as set forth in SEQ ID NO: 6; DNA molecules that encode for proteins, BigL1, BigL2 and BigL3 in the Leptospira sp bacterium; diagnostic, therapeutic and vaccine applications; leptospirosis; spirochetesveterinary medicine; humans
05/17/2007US20070110763 Polypeptides of streptococcus pyogenes
05/17/2007US20070110762 Process for preparing polysaccharide-protein conjugate vaccines
05/17/2007US20070110759 Methods
05/17/2007US20070110755 Vascular endothelial cell growth factor antagonists
05/17/2007US20070110749 Centrosome proteins and uses thereof
05/17/2007US20070110748 Fibronectin binding protein compositions and methods of use
05/17/2007US20070110746 Pharmaceutical composition for treatment of immunological disorders
05/17/2007US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders
05/17/2007US20070110744 Lymphatic and blood endothelial cell genes
05/17/2007US20070110742 Recombinant peptide vector comprising the gene for treatment for autoimmune diseases
05/17/2007US20070110733 Compositions and methods for stem cell delivery
05/17/2007US20070110723 Delivery of trefoil peptides
05/17/2007US20070110713 Novel multifunctional cytokines
05/17/2007US20070110712 Method of modulating fertility in animals
05/17/2007US20070110711 Agent for enhancing the production of cytokines and/or chemokines
05/17/2007US20070110698 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
05/17/2007US20070110686 Peptide-based organic sunscreens
05/17/2007US20070110673 Allergen peptide fragments and use thereof
05/16/2007EP1785487A2 Polypeptides involved in the expression of resistance to glycopeptide antibiotics
05/16/2007EP1785486A2 Streptococcus pneumoniae proteins and nucleic acid molecules
05/16/2007EP1785485A1 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress
05/16/2007EP1785433A1 Viral particle-like construct and method of forming the same under physiological conditions
05/16/2007EP1784510A2 Irak1c splice variant and its use